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A commentary on
Rheumatoid cachexia revisited: a metabolic co-morbidity in rheumatoid arthritis
by Masuko K. Front Nutr (2014) 1:20. doi: 10.3389/fnut.2014.00020
The “mini review” by Masuko (1) contains a quite extensive summary of “rheumatoid cachexia” 
(2) [i.e., loss of muscle mass in rheumatoid arthritis (RA)], an often overlooked and misdiagnosed 
co-morbidity. Masuko looks at the definition of “rheumatoid cachexia,” as well as the pathogenesis of 
the condition referring to the key role of pro-inflammatory cytokines. Interestingly, various strategic 
therapy options designed to attenuate rheumatoid cachexia by disease-modifying anti-rheumatic 
drugs (DMARDS), anti-cytokine therapies, and exercise training (i.e., resistance and endurance) 
are covered.
However, what the review fails to mention or expand upon, is the relative ineffectiveness of 
exercise on “rheumatoid cachexia” once supervision is withdraw. The review also neglects to discuss 
(despite referencing a relevant trial) another potential key tool in the armory against “rheumatoid 
cachexia”: nutritional supplementation. This commentary will confine itself to briefly recounting 
some of these.
As Masuko states that resistance training is the most beneficial means to increase both lean mass 
and physical function in RA. Both Marcora et al. (3) and Lemmey et al. (4) showed that progressive 
resistance training (PRT) for a period of 12 and 24 weeks (exercising two and three times per week, 
respectively) was able to attenuate the effects of rheumatoid cachexia, specifically increasing lean 
mass, strength, and physical function in patients with RA. However, a follow-up study for 3 years 
later by Lemmey et al. (5) found that once supervision was withdrawn, no subjects from the original 
study (4) were performing relevant PRT or any other form of regular high intense exercise and, as 
a result, lean mass had regressed to baseline levels, as had much of the trunk fat mass and body fat 
percentage. Lack of adherence to high-intense exercise in RA has been demonstrated by others (6).
Unfortunately, it seems habitually performed, high-intensity exercise (i.e., PRT) is unlikely to be 
widely adopted as a general treatment strategy for reversing “rheumatoid cachexia” and restoring 
function, then the challenge to develop a treatment option that is easily administered, inexpensive, 
and makes limited demands of the patient remains. Anabolic nutritional supplementation offers a 
potential treatment option that is easily administered, inexpensive, and makes limited demands of 
the patient.
Scientific evidence continues to suggest that nutrition should be part of routine care in 
those with muscle wasting disorders [for review, see Stamp et al. (7)]. Specifically, up to 75% of 
RA patients believe that food and nutrition play an important role in their symptom severity, 
with 50% of RA patients reportedly trying some form of dietary manipulation in an attempt 
to attenuate symptomology (7). Marcora et  al. (8) previously investigated the effects of daily 
12  weeks of a mixture of β-hydroxy-β-methylbutyrate, glutamine, and arginine (HMB/GLN/
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ARG) protein supplementation in 40 RA patients. The results 
showed that both HMB/GLN/ARG and a control mixture 
of other non-essential amino acids (alanine, glutamic acid, 
glycine, and serine) were both equally effective in increasing 
lean mass (~0.4 kg) and improving some measures of physical 
function and strength.
Creatine monohydrate, a combination of essential amino 
acids, has generally been shown to be more effective in increas-
ing lean mass and physical performance than other protein-based 
supplements, including HMB/GLN/ARG [for review, see Nissen 
(9)]. In the only study investigating the use of creatine in RA, 
Willer et al. (10) found that creatine supplementation increased 
muscle strength in 8 out of the 12 patients by an average of 14% as 
determined by the muscle strength index, although this increase 
in strength was not actually associated with changes of creatine 
(or phosphocreatine) levels in the muscle.
Nonetheless, creatine has been shown to be effective, without 
additional exercise training, in range of clinical populations, 
including muscular dystrophy patients and the elderly who, like 
RA patients, present with reduced muscle mass and impaired 
physical function [for review, see Wilkinson et al. (11)]. Evidently, 
more research is needed, and as such we have just completed a 
randomized control trial investigating the effects of creatine in 
RA patients (manuscript in preparation).
To summarize, although PRT exercise is arguably the most 
effective way to attenuate the effects of rheumatoid cachexia, due 
to its high-intense nature, it is unlikely to be widely adopted as a 
general treatment strategy. Nutritional supplementation, specifi-
cally those that focus on muscle anabolism may be a viable option. 
Alongside, HMB/GLN/ARG protein supplementation, creatine 
monohydrate may be a potential therapeutic option in RA, as it 
has been effective in range of clinical and elderly populations.
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